Class information for:
Level 1: MTOR//RAPAMYCIN//CCI 779

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1139 2730 52.0 92%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
625 13166 PTEN//MTOR//LHERMITTE DUCLOS DISEASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MTOR Author keyword 111 18% 21% 563
2 RAPAMYCIN Author keyword 62 16% 13% 357
3 CCI 779 Author keyword 58 83% 1% 33
4 RICTOR Author keyword 39 57% 2% 47
5 RAD001 Author keyword 38 49% 2% 56
6 MTORC2 Author keyword 37 53% 2% 49
7 MTORC1 Author keyword 35 31% 3% 95
8 EVEROLIMUS Author keyword 34 17% 7% 184
9 RHEB Author keyword 33 48% 2% 51
10 TEMSIROLIMUS Author keyword 31 29% 3% 91

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 MTOR 111 18% 21% 563 Search MTOR Search MTOR
2 RAPAMYCIN 62 16% 13% 357 Search RAPAMYCIN Search RAPAMYCIN
3 CCI 779 58 83% 1% 33 Search CCI+779 Search CCI+779
4 RICTOR 39 57% 2% 47 Search RICTOR Search RICTOR
5 RAD001 38 49% 2% 56 Search RAD001 Search RAD001
6 MTORC2 37 53% 2% 49 Search MTORC2 Search MTORC2
7 MTORC1 35 31% 3% 95 Search MTORC1 Search MTORC1
8 EVEROLIMUS 34 17% 7% 184 Search EVEROLIMUS Search EVEROLIMUS
9 RHEB 33 48% 2% 51 Search RHEB Search RHEB
10 TEMSIROLIMUS 31 29% 3% 91 Search TEMSIROLIMUS Search TEMSIROLIMUS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 MAMMALIAN TARGET 401 26% 49% 1331
2 MTOR 112 21% 18% 483
3 RAPAMYCIN 88 14% 21% 585
4 BINDING PARTNER 86 43% 6% 156
5 RICH AKT SUBSTRATE 85 72% 2% 67
6 RAG GTPASES 83 50% 4% 120
7 40 KDA PRAS40 73 85% 1% 39
8 DEFOROLIMUS AP23573 73 89% 1% 33
9 P70 S6 KINASE 73 22% 11% 289
10 TEMSIROLIMUS CCI 779 62 67% 2% 56

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
mTOR Signaling in Growth Control and Disease 2012 1325 172 66%
mTOR: from growth signal integration to cancer, diabetes and ageing 2011 1183 170 49%
Making new contacts: the mTOR network in metabolism and signalling crosstalk 2014 77 81 67%
Regulation of mTORC1 by amino acids 2014 57 84 58%
Molecular mechanisms of mTOR-mediated translational control 2009 752 115 55%
Defining the role of mTOR in cancer 2007 1304 130 52%
TOR signaling in growth and metabolism 2006 2539 109 50%
mTOR: a pharmacologic target for autophagy regulation 2015 5 112 66%
Amino acid signalling upstream of mTOR 2013 123 51 51%
Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress 2010 451 168 51%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 SERV MED INTERNE UF HEMATOL 4 56% 0.2% 5
2 DIPARTIMENTO SCI ANAT UMANE 3 57% 0.1% 4
3 UMRS 845 2 36% 0.2% 5
4 MIRO 2 67% 0.1% 2
5 SURG MED DENT MORPHOL 2 67% 0.1% 2
6 UF HEMATOL 1 38% 0.1% 3
7 CLIN COLORECTAL TUMOR 1 100% 0.1% 2
8 MONTABONE UNIT NEW DRUG DEV 1 50% 0.1% 2
9 SECT MOL ONCOL LUNG CANC 1 100% 0.1% 2
10 SPECT SUPPORT IL 1 100% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000179552 S6K2//S6 KINASE//RIBOSOMAL S6 KINASE 2 S6K2
2 0.0000142883 T CELL METABOLISM//UAB MITOCHONDRIAL MED//BZ 423
3 0.0000118986 P110 ALPHA//PIK3CA//PI3K ALPHA
4 0.0000117369 EIF4E//EIF 4E//CAPPING EFFICIENCY
5 0.0000111305 PDK1//AKT ISOFORMS//AKT2
6 0.0000090780 TUBEROUS SCLEROSIS//TUBEROUS SCLEROSIS COMPLEX//SUBEPENDYMAL GIANT CELL ASTROCYTOMA
7 0.0000079331 SESTRIN 2//TP53INP1//SESTRIN
8 0.0000058148 RSP5 UBIQUITIN LIGASE//GLN3//RSP5
9 0.0000057740 SIROLIMUS//EVEROLIMUS//PROLIFERATION SIGNAL INHIBITORS
10 0.0000051879 SUNITINIB//METASTATIC RENAL CELL CARCINOMA//CARCINOMA RENAL CELL